Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume 27, Issue 10, Pages 1105-1117
Publisher
Wiley
Online
2021-08-07
DOI
10.1111/cns.13714
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages
- (2021) Natalia Ochocka et al. Nature Communications
- Vascular priming with RRx-001 to increase the uptake and accumulation of temozolomide and irinotecan in orthotopically implanted gliomas
- (2021) Bryan Oronsky et al. JOURNAL OF DRUG TARGETING
- Glioblastoma precision therapy: From the bench to the clinic
- (2020) Yuan Zhou et al. CANCER LETTERS
- Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
- (2020) Wahafu Alafate et al. CNS Neuroscience & Therapeutics
- B3GNT5 is a novel marker correlated with stem‐like phenotype and poor clinical outcome in human gliomas
- (2020) Hang Yeon Jeong et al. CNS Neuroscience & Therapeutics
- Effect of intra‐ and inter‐tumoral heterogeneity on molecular characteristics of primary IDH‐wild type glioblastoma revealed by single‐cell analysis
- (2020) Zujian Xiong et al. CNS Neuroscience & Therapeutics
- Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
- (2019) Gregor Hutter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
- (2019) Junfei Zhao et al. NATURE MEDICINE
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Molecular responses to immune checkpoint blockade in glioblastoma
- (2019) Hirotaka Ito et al. NATURE MEDICINE
- Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans
- (2019) Andreas Stadlbauer et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
- (2019) Rüdiger Klapdor et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Heparanase promotes glioma progression via enhancing CD24 expression
- (2019) Uri Barash et al. INTERNATIONAL JOURNAL OF CANCER
- Quantitative parametric maps of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in diffuse glioma
- (2019) Thomas Koopman et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
- (2019) Maisa C. Takenaka et al. NATURE NEUROSCIENCE
- Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma
- (2019) Jia Wang et al. CNS Neuroscience & Therapeutics
- Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
- (2019) Ryan C. Gimple et al. GENES & DEVELOPMENT
- Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47
- (2019) Weige Tan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- Mechanisms of immunotherapy resistance: lessons from glioblastoma
- (2019) Christopher M. Jackson et al. NATURE IMMUNOLOGY
- The Role of Checkpoint Inhibitors in Glioblastoma
- (2019) Kunal Desai et al. Targeted Oncology
- Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
- (2019) Xuyao Zhang et al. Journal for ImmunoTherapy of Cancer
- Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies
- (2018) Sandeep Mittal et al. JOURNAL OF NEUROSURGERY
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- Multidimensional communication in the microenvirons of glioblastoma
- (2018) Marike L. Broekman et al. Nature Reviews Neurology
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
- (2018) Pakawat Chongsathidkiet et al. NATURE MEDICINE
- Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticity
- (2018) Kamalakannan Palanichamy et al. EBioMedicine
- Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients
- (2018) Qing Guo et al. CNS Neuroscience & Therapeutics
- Altered hemodynamics contribute to local but not remote functional connectivity disruption due to glioma growth
- (2018) Inema E Orukari et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple-Negative Breast Cancer
- (2018) Shih-Hsuan Chan et al. MOLECULAR CANCER THERAPEUTICS
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Intra-tumor heterogeneity from a cancer stem cell perspective
- (2017) Pramudita R. Prasetyanti et al. Molecular Cancer
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells
- (2017) Feng Li et al. OncoImmunology
- CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
- (2017) Vita Golubovskaya et al. Cancers
- Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
- (2016) Hong Jiang et al. NATURE MEDICINE
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer
- (2016) Xinying Wang et al. Oncotarget
- Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
- (2016) Michael Zhang et al. PLoS One
- Innate Immune Recognition of Cancer
- (2015) Seng-Ryong Woo et al. Annual Review of Immunology
- Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
- (2015) M. Cioffi et al. CLINICAL CANCER RESEARCH
- Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma
- (2015) Pei Zhang et al. JOURNAL OF SURGICAL RESEARCH
- Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
- (2015) Yu Tang et al. MOLECULAR NEUROBIOLOGY
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Immunosuppressive mechanisms in glioblastoma: Fig. 1.
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro
- (2015) ZHEN PEI et al. ONCOLOGY REPORTS
- Glioma-Associated Microglia/Macrophages Display an Expression Profile Different from M1 and M2 Polarization and Highly Express Gpnmb and Spp1
- (2015) Frank Szulzewsky et al. PLoS One
- New insights into pancreatic cancer stem cells
- (2015) Chinthalapally V Rao World Journal of Stem Cells
- Microglia: unique and common features with other tissue macrophages
- (2014) Marco Prinz et al. ACTA NEUROPATHOLOGICA
- Microglia as a critical player in both developmental and late-life CNS pathologies
- (2014) Noël C. Derecki et al. ACTA NEUROPATHOLOGICA
- CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
- (2014) D. R. Soto-Pantoja et al. CANCER RESEARCH
- Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target
- (2014) Melanie Jackson et al. CARCINOGENESIS
- BASI, A Potent Small Molecular Inhibitor, Inhibits Glioblastoma Progression by Targeting microRNA-mediatedβ-Catenin Signaling
- (2014) Zhen-Dong Shi et al. CNS Neuroscience & Therapeutics
- Suppression of TRPM7 Inhibits Proliferation, Migration, and Invasion of Malignant Human Glioma Cells
- (2014) Tian-Dong Leng et al. CNS Neuroscience & Therapeutics
- Increased Expression of Capn4 is Associated with the Malignancy of Human Glioma
- (2014) Jia-Jun Cai et al. CNS Neuroscience & Therapeutics
- Post-translational Glycoprotein Modifications Regulate Colon Cancer Stem Cells and Colon Adenoma Progression in Apcmin/+Mice through Altered Wnt Receptor Signaling
- (2014) Huabei Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
- (2014) Paola Italiani et al. Frontiers in Immunology
- The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
- (2013) A. Neil Barclay et al. Annual Review of Immunology
- Novel CD47: SIRPα Dependent Mechanism for the Activation of STAT3 in Antigen-Presenting Cell
- (2013) Natan Toledano et al. PLoS One
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
- (2013) A. Sottoriva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of Tumor Tolerance in Primary Central Nervous System Malignancies
- (2012) Theodore S. Johnson et al. Clinical & Developmental Immunology
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas
- (2012) Jianping Deng et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct Measurements on CD24-Mediated Rolling of Human Breast Cancer MCF-7 Cells on E-Selectin
- (2011) Ja Hye Myung et al. ANALYTICAL CHEMISTRY
- CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization
- (2011) J. B. Overdevest et al. CANCER RESEARCH
- CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion
- (2011) Niko Bretz et al. CLINICAL & EXPERIMENTAL METASTASIS
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
- (2011) Stuart A. Grossman et al. CLINICAL CANCER RESEARCH
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Physiology of Microglia
- (2011) Helmut Kettenmann et al. PHYSIOLOGICAL REVIEWS
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- CD24: from A to Z
- (2010) Xianfeng Fang et al. Cellular & Molecular Immunology
- Microglia/macrophages promote glioma progression
- (2010) Haiyan Zhai et al. GLIA
- Glioma cancer stem cells induce immunosuppressive macrophages/microglia
- (2010) Adam Wu et al. NEURO-ONCOLOGY
- Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
- (2010) M. P. Chao et al. Science Translational Medicine
- Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease
- (2009) A. Kukreja et al. BLOOD
- CD47 Regulates Bone Mass and Tumor Metastasis to Bone
- (2009) O. Uluckan et al. CANCER RESEARCH
- CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation
- (2009) Weifei Wang et al. CANCER SCIENCE
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Lewisx and 2,3-Sialyl Glycans and Their Receptors TAG-1, Contactin, and L1 Mediate CD24-Dependent Neurite Outgrowth
- (2009) A. Lieberoth et al. JOURNAL OF NEUROSCIENCE
- Flow cytometry and in vitro analysis of human glioma–associated macrophages
- (2009) Ian F. Parney et al. JOURNAL OF NEUROSURGERY
- CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
- (2009) G.-Y. Chen et al. SCIENCE
- Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
- (2008) Richard K. Tsai et al. JOURNAL OF CELL BIOLOGY
- Rod-Shaped Monocytes Patrol the Brain Vasculature and Give Rise to Perivascular Macrophages under the Influence of Proinflammatory Cytokines and Angiopoietin-2
- (2008) J. Audoy-Remus et al. JOURNAL OF NEUROSCIENCE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Innate immune ‘self’ recognition: a role for CD47–SIRPα interactions in hematopoietic stem cell transplantation
- (2008) Timo K. van den Berg et al. TRENDS IN IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started